Advanced Biomedical Engineering is a peer-reviewed open access journal published by the Japanese Society for Medical & Biological Engineering, dedicated to disseminating high-quality research in the multidisciplinary fields of biomedical engineering. Boasting an ISSN of 2187-5219, this journal has been pivotal since its inception in 2018, especially as it embraces the open access model to foster knowledge sharing and wide accessibility. Centered in Tokyo, Japan, it serves as a vital platform for scholars and practitioners across various domains, such as biomaterials, biomedical engineering, and biotechnology. Despite currently residing in the Q4 quartile across several categories, including those in biotechnology and computer science applications, the journal is committed to elevating its academic impact and reputation, aiming for improved rankings in Scopus and other databases. Researchers and professionals are encouraged to contribute their innovative findings, discussions, and case studies, facilitating the advancement of this dynamic field.

TECHNOLOGY AND HEALTH CARE, published by IOS PRESS, stands as a prominent interdisciplinary journal dedicated to the integration of technology within the healthcare sector. With an ISSN of 0928-7329 and an E-ISSN of 1878-7401, this journal has been a vital resource since its inception in 1993, providing insights and advancements in various categories including bioengineering, biomedical engineering, health informatics, and more. Though it currently holds a Q4 classification in several fields and Q3 in others, it actively contributes to the dialogue surrounding innovative methodologies and practices that enhance healthcare delivery. Researchers, professionals, and students will find the journal invaluable for its diverse range of studies that explore the convergence of technology and health. Its commitment to fostering impactful research continues to reinforce its relevance in the evolving landscape of healthcare technology.

Intelligent Medicine, published by Elsevier, is a leading open-access journal dedicated to advancing the fields of Artificial Intelligence, Biomedical Engineering, Health Informatics, and related areas within Medicine. Since its inception in 2021, it has quickly established itself among the top tier of academic publications, holding a commendable Q2 ranking in several categories, including a rank of #51 in Health Informatics and #104 in Medicine (Miscellaneous) as of 2023. The journal aims to disseminate innovative research that harnesses AI technologies to improve healthcare outcomes, bridging the gap between cutting-edge technology and medical practice. With its open-access model, Intelligent Medicine ensures broad dissemination of research findings, facilitating collaboration and knowledge sharing among researchers, practitioners, and students globally. Located in Amsterdam, Netherlands, this journal plays a pivotal role in shaping the future of intelligent healthcare solutions, inviting submissions that push the boundaries of conventional medicine through creative and impactful research.

Journal of Integrative Bioinformatics, published by WALTER DE GRUYTER GMBH, is a leading open-access journal that has been at the forefront of the field since its inception in 2004. With an E-ISSN of 1613-4516, it serves as a crucial platform for researchers engaged in the interdisciplinary study of bioinformatics, blending insights from biology, computer science, and mathematics. Based in Germany, the journal is recognized for its impact in the realm of general medicine, boasting a Scopus rank of #172 out of 636 and placing in the 73rd percentile of its category. The journal continuously strives to disseminate high-quality research contributions that unify experimental and computational approaches to address complex biomedical questions. Targeted towards academics, professionals, and students alike, the Journal of Integrative Bioinformatics provides essential access to innovative research that enhances our understanding of integrative methodologies in medicine and beyond, especially with converged years spanning from 2008 to 2024.

AIMS Bioengineering, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing knowledge in the interdisciplinary field of bioengineering. With the ISSN 2375-1495, this journal has been providing a platform for the rapid dissemination of high-quality research since its establishment in 2014. AIMS Bioengineering covers a wide range of topics, including but not limited to, biomaterials, computational biology, and bioinformatics, making it an essential resource for researchers, professionals, and students alike. Although the H-index and specific category quartiles are not currently available, the journal's commitment to open access ensures that cutting-edge findings are accessible to a global audience, fostering collaboration and innovation in bioengineering. With its rigorous peer-review process and dedication to scholarly excellence, AIMS Bioengineering continues to play a pivotal role in shaping the future of the bioengineering landscape.

Biomedical Signal Processing and Control is a premier academic journal published by ELSEVIER SCI LTD that stands at the forefront of the rapidly evolving fields of biomedical engineering, health informatics, and signal processing. With an impressive impact factor reflecting its scholarly influence and high standards of research, this journal has been recognized in the Q1 quartile category across multiple disciplines as of 2023. Specifically, it holds esteemed positions within Biomedical Engineering, Health Informatics, and Signal Processing, where it ranks in the top tier of its field on Scopus: #19/131, #21/138, and #47/303 respectively. Published continually from 2006 to 2024, the journal serves as a critical platform for researchers, healthcare professionals, and students, fostering innovation in signal processing techniques and their applications in biomedical systems. Access to cutting-edge research and methodologies makes it an indispensable resource for advancing knowledge and practice within these interdisciplinary domains.

Nature Biomedical Engineering is a premier journal published by NATURE PORTFOLIO, focusing on innovative research at the intersection of engineering and biomedical sciences. With an ISSN of 2157-846X, this journal aims to disseminate groundbreaking studies that advance the field of bioengineering, biotechnology, and medical applications. Since its inception in 2017, it has rapidly earned a reputation for excellence, consistently achieving a Q1 ranking in various categories including Bioengineering and Biomedical Engineering, and receiving acclaim in prestigious Scopus rankings, boasting top positions in the fields of Computer Science Applications and Medicine. The journal operates under a rigorous peer-review process, ensuring that all published articles contribute substantially to the existing body of knowledge. Furthermore, it facilitates a broad accessibility model for researchers and practitioners, bolstering collaboration and innovation within the global scientific community. Nature Biomedical Engineering is not just a publication; it serves as a vital platform for thought leadership in the transformative field of biomedical engineering.

The International Journal of Biomedical Engineering and Technology, published by INDERSCIENCE ENTERPRISES LTD, serves as a pivotal platform for the dissemination of innovative research in the field of biomedical engineering. This journal, with ISSN 1752-6418 and E-ISSN 1752-6426, has been a valuable resource since its inception in 2007, boasting a converged publication timeline extending to 2024. Based in the United Kingdom, the journal aims to bridge the gap between engineering and biomedical sciences, facilitating interdisciplinary collaboration. As reflected in its 2023 Scopus ranking in the Q4 quartile of Biomedical Engineering, the journal remains accessible for researchers at various stages of their careers, contributing to its significance in promoting advancements in healthcare technologies. While currently not an open-access publication, the journal remains dedicated to enriching the biomedical engineering community by presenting novel research that addresses critical challenges, ultimately aiming to improve patient outcomes and drive innovation in medical devices and therapies.

Current Opinion in Biomedical Engineering is a renowned journal published by Elsevier, focusing on the cutting-edge developments and critical assessments in the fields of biomedical engineering and related disciplines. With an ISSN of 2468-4511, it provides a valuable platform for researchers and professionals to disseminate their insights and discoveries in areas such as bioengineering, biomaterials, and medicine. Its impressive impact factor positions it in the Q2 category for several fields, including Bioengineering and Biomedical Engineering, highlighting its influence and relevance in ongoing scientific dialogues. The journal’s unique format of opinion pieces and reviews encourages innovative thinking and fosters collaboration among experts. As an essential resource for those engaged in the life sciences and engineering, Current Opinion in Biomedical Engineering serves to stimulate discussion, promote knowledge exchange, and drive advancements in biomedical applications. Set in the Netherlands at Radarweg 29, 1043 NX Amsterdam, the journal is accessible through various academic platforms, enabling a global readership to engage with the latest scholarly work in this dynamic field.

Biomedical Engineering Online, published by BMC, is an esteemed open-access journal in the United Kingdom that has been advancing the field of biomedical engineering since its inception in 2002. With a commitment to disseminating high-quality research, the journal encompasses a broad scope, including innovative studies in biomaterials, imaging technologies, and medical applications. Recognized within the Q2 quartile for various categories such as Biomaterials and Biomedical Engineering, it ranks favorably among its peers: Rank #58 out of 333 in Radiology, and Rank #15 out of 63 in Radiological and Ultrasound Technology in the Scopus database. These rankings, coupled with an open-access model, ensure that critical advancements in medical technology are accessible to researchers, health professionals, and students globally. As it continues through its converged years from 2002 to 2024, Biomedical Engineering Online remains an invaluable resource for anyone involved in the cutting-edge intersection of engineering and medicine.